In most cancer types, CD8+ T cell infiltration in tumors predicts a good prognosis (Disis et al., 2019; Shimizu et al., 2019), while regulatory T (Treg) cells are known to suppress the anti-tumor immune responses and are usually correlated with a poor outcome (Sharma et al., 2019). This evidence concerns the gene CD8A and cancer.